B-Cell Translocation Gene 4 (BTG4) (Middle Region) Peptide
-
- Target See all BTG4 products
- BTG4 (B-Cell Translocation Gene 4 (BTG4))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BTG4 antibody (Catalog #: ARP56981_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BTG4 (B-Cell Translocation Gene 4 (BTG4))
- Background
-
The protein encoded by this gene is a member of the BTG/Tob family. This family has structurally related proteins that appear to have antiproliferative properties. This encoded protein can induce G1 arrest in the cell cycle.
Alias Symbols: MGC33003, PC3B
Protein Size: 223 - Molecular Weight
- 26 kDa
- Gene ID
- 54766
- NCBI Accession
- NM_017589, NP_060059
- UniProt
- Q9NY30
-